Ignite Creation Date:
2025-12-24 @ 6:40 PM
Ignite Modification Date:
2025-12-29 @ 5:53 AM
Study NCT ID:
NCT06203457
Status:
COMPLETED
Last Update Posted:
2025-04-03
First Post:
2023-11-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Open-Label Extension Study to Evaluate the Safety of Efgartigimod in Adult Patients With Primary Sjögren's Syndrome
Sponsor:
argenx
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-08-15
Start Date Type:
ACTUAL
Primary Completion Date:
2025-02-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-02-03
Completion Date Type:
ACTUAL
First Submit Date:
2023-11-16
First Submit QC Date:
None
Study First Post Date:
2024-01-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-02
Last Update Post Date:
2025-04-03
Last Update Post Date Type:
ACTUAL